Dual targeting of ErbB1 and ErbB2 enhances response to chemotherapy in ErbB2 overexpressing breast cancer cell lines.

被引：0
|
作者：
O'Donovan, N.
Clynes, M.
Crown, J.
机构：
[1] Dublin City Univ, Dublin 9, Ireland
[2] St Vincents Univ Hosp, Dublin, Ireland
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [21] Growth inhibitory effects and mechanisms of lapatinib, a dual inhibitor of ErbB1 and ErbB2 tyrosine kinase, in gastric cell lines
    Kim, J. W.
    Im, S. A.
    Kim, H. P.
    Oh, D. Y.
    Kim, T. Y.
    Bang, Y. J.
    EJC SUPPLEMENTS, 2007, 5 (04): : 262 - 262
  • [22] Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer
    Singla, Smit
    Pippin, James A.
    Drebin, Jeffrey A.
    ONCOLOGY REPORTS, 2012, 28 (06) : 2211 - 2216
  • [23] Dual inhibition of ErbB1 (EGFR/HER1) and ErbB2 (HER2/neu)
    Reid, Alison
    Vidal, Laura
    Shaw, Heather
    de Bono, Johann
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (03) : 481 - 489
  • [24] Antiproliferative effects of rapamycin and doxorubicin combination on human Erbb2 overexpressing breast epithelial cell lines.
    Trape, Adriana
    Katayama, Maria Hirata
    Roela, Rosimeire
    Tortelli, Tharcisio
    Ravacci, Graziela
    Brentani, M.
    CANCER RESEARCH, 2009, 69
  • [25] Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells
    Xia, WL
    Gerard, CM
    Liu, LH
    Baudson, NM
    Ory, TL
    Spector, NL
    ONCOGENE, 2005, 24 (41) : 6213 - 6221
  • [26] Differential cytoskeletal association of ErbB1 and ErbB2 during keratinocyte differentiation
    Kansra, S
    Stoll, SW
    Elder, JT
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (05) : 1108 - 1117
  • [27] Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells
    Wenle Xia
    Catherine M Gerard
    Leihua Liu
    Nathalie M Baudson
    Thierry L Ory
    Neil L Spector
    Oncogene, 2005, 24 : 6213 - 6221
  • [28] ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines
    C Ginestier
    J Adélaïde
    A Gonçalvès
    L Repellini
    F Sircoulomb
    A Letessier
    P Finetti
    J Geneix
    E Charafe-Jauffret
    F Bertucci
    J Jacquemier
    P Viens
    D Birnbaum
    Oncogene, 2007, 26 : 7163 - 7169
  • [29] ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines
    Ginestier, C.
    Adelaiede, J.
    Goncalves, A.
    Repellini, L.
    Sircoulomb, F.
    Letessier, A.
    Finetti, P.
    Geneix, J.
    Charafe-Jauffret, E.
    Bertucci, F.
    Jacquemier, J.
    Viens, P.
    Birnbaum, D.
    ONCOGENE, 2007, 26 (50) : 7163 - 7169
  • [30] ETHANOL ENHANCES THE INTERACTION OF BREAST CANCER CELLS OVEREXPRESSING ERBB2 WITH EXTRACELLULAR MATRIX
    Luo, J.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 265A - 265A
12345